Tech Company Financing Transactions

Phenomix Sciences Funding Round

Phenomix Sciences closed a $7.8 million venture capital round on 5/16/2024. Investors included Dexcom, Health2047 Capital Partners and LabCorp.

Transaction Overview

Company Name
Announced On
5/16/2024
Transaction Type
Venture Equity
Amount
$7,800,000
Round
Undisclosed
Proceeds Purpose
This capital will accelerate the commercialization and adoption of the MyPhenome� test in the obesity specialist market and the wider industry. The funds will also enable the company to develop and launch additional phenotyping tests, continue to support clinical studies and patent novel insights, and further strategic relationships with pharmaceutical companies and health care providers.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
18202 Minnetonka Blvd
Wayzata, MN 55391
USA
Phone
Undisclosed
Email Address
Overview
Unfortunately, obesity rates have doubled in the last 20 years. Without changes, 50% of the adult population will be obese by 2030. To address the challenges, science has brought us new medications - not all of them successful and more than a few with severe side effects. While medications come and go, complications associated with surgery and diets have come and stayed.
Profile
Phenomix Sciences LinkedIn Company Profile
Social Media
Phenomix Sciences Company Twitter Account
Company News
Phenomix Sciences News
Facebook
Phenomix Sciences on Facebook
YouTube
Phenomix Sciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Mark Bagnall
  Mark Bagnall LinkedIn Profile  Mark Bagnall Twitter Account  Mark Bagnall News  Mark Bagnall on Facebook
Chief Operating Officer
Liv Williamsen
  Liv Williamsen LinkedIn Profile  Liv Williamsen Twitter Account  Liv Williamsen News  Liv Williamsen on Facebook
Chief Scientific Officer
Tim O'Connor
  Tim O'Connor LinkedIn Profile  Tim O'Connor Twitter Account  Tim O'Connor News  Tim O'Connor on Facebook
Co-Founder
Andres Acosta
  Andres Acosta LinkedIn Profile  Andres Acosta Twitter Account  Andres Acosta News  Andres Acosta on Facebook
Co-Founder
Michael Camilleri
  Michael Camilleri LinkedIn Profile  Michael Camilleri Twitter Account  Michael Camilleri News  Michael Camilleri on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/16/2024: HEPHAISTOS-Pharma venture capital transaction
Next: 5/16/2024: CoLab Software venture capital transaction

 

Share this article

 


About Database of VC Transactions

We report on funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary